Proof Diagnostics Seeks Emergency Use Authorization of CRISPER-Based POC COVID Test
Proof Diagnostics announced the submission of its EUA request for review to the U.S. FDA for its POC molecular diagnostic test for COVID-19.
Read MorePosted by Andy Lundin | Apr 11, 2022 | Covid 19, Immunoassay Reagents & test Kits |
Proof Diagnostics announced the submission of its EUA request for review to the U.S. FDA for its POC molecular diagnostic test for COVID-19.
Read MorePosted by Andy Lundin | Apr 11, 2022 | Covid 19, Immunoassay Reagents & test Kits |
Researchers have helped developed a COVID testing device that can detect infection in as little as 30 seconds as accurately as a PCR test.
Read MorePosted by Andy Lundin | Apr 8, 2022 | Covid 19 |
The research group tested nanotechnology-based optical sensors designed for COVID detection and saw the potential for their home-grown tech.
Read MorePosted by Andy Lundin | Apr 7, 2022 | Company News, Point-of-Care |
Cue Health is now offering its point-of-care solutions for BioReference’s clinical customers, including healthcare providers and POC clinics.
Read MorePosted by Andy Lundin | Apr 7, 2022 | Covid 19 |
A family of proteins that is elevated in the saliva of COVID patients could help doctors identify those who are at risk of serious illness.
Read More